| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2010 | Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions | Ahn S.H.; Chan H.L.Y.; PEI-JER CHEN ; Cheng J.; Goenka M.K.; Hou J.; Lim S.G.; Omata M.; Piratvisuth T.; Xie Q.; Yim H.J.; Yuen M.-F. | Hepatology International | 41 | ||
| 2014 | Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study | Kim K.; Lee J.H.; Kim J.S.; Min C.K.; Yoon S.S.; Shimizu K.; Chou T.; Kosugi H.; Suzuki K.; Chen W.; Hou J.; Lu J.; Huang X.-J.; SHANG-YI HUANG ; Chng W.J.; Tan D.; Teoh G.; Chim C.S.; Nawarawong W.; Siritanaratkul N.; Durie B.G. | American Journal of Hematology | 58 | ||
| 2019 | Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: A systematic review and meta-analysis of individual participant data | Pavlovic V.; Yang L.; Chan H.L.-Y.; Hou J.; Janssen H.L.; JIA-HORNG KAO ; Lampertico P.; Peng C.-Y.; Piratvisuth T.; Thompson A.J.; Wedemeyer H.; Wei L.; Wat C. | Antiviral Therapy | 7 | ||
| 2012 | Re-evaluation of the Carcinogenic Significance of Hepatitis B Virus Integration in Hepatocarcinogenesis | Jiang S.; Yang Z.; Li W.; Li X.; Wang Y.; Zhang J.; Xu C.; PEI-JER CHEN ; Hou J.; McCrae M.A.; Chen X.; Zhuang H.; Lu F. | PLoS ONE | 58 | ||
| 2018 | Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop | Tan D.; Lee J.H.; Chen W.; Shimizu K.; Hou J.; Suzuki K.; Nawarawong W.; SHANG-YI HUANG ; Sang Chim C.; Kim K.; Kumar L.; Malhotra P.; Chng W.J.; Durie B.; for the Asian Myeloma Network | Leukemia and Lymphoma | 9 |
